Investment in equity securities, at fair value and long-term investments (Tables)

6 Months Ended

Jun. 30, 2021

Investment in equity securities, at fair value and long-term investments

Schedule of investment

				Gross
(In thousands)				unrealized		Aggregate fair
Description	Classification	Cost		gains		value
MaxCyte - equity interest	Investment	$	—	$	4,709	$	4,709
BioInvent - equity interest	Investment	$	5,661	$	2,218	$	7,879
Total						$	12,588

Schedule of components of long-term investments

	June 30,		December 31,
(In thousands)	2021		2020
Available-for-sale debt securities:
Black Belt Tx Limited - convertible loan	$	169	$	83
Securities measured at fair value:
BioInvent International AB - warrants		996		840
Cleave Therapeutics, Inc. - convertible loan		5,547		—
Equity securities without readily determinable fair value:
Black Belt Tx Limited - equity interest		1,385		2,250
Juventas Cell Therapy Ltd - equity interest		26,370		26,059
Juventas Cell Therapy Ltd - put option		212		210
Total	$	34,679	$	29,442